Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Lile Method Research LLC has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct examiners and a matching number of distinct art units, showing a distributed examiner pool for its current filings. This distribution suggests that the company's intellectual property covers varied technical sub-fields within the broader biotechnology sector.
SEAMAN, D MARGARET M is identified as the busiest examiner, though they are responsible for only 1 pending office action. This distribution indicates that the workload is shared among the assigned staff. For the practitioner, this means that the prosecution of the pending office actions will proceed independently, with no single examiner's perspective dominating the portfolio's current trajectory. The presence of multiple art units for a small number of actions highlights a decentralized review process for this specific portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SEAMAN, D MARGARET M | 1 | 76.5% | +8.0% |
| REYNOLDS, FRED H | 1 | 33.0% | +39.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18370919 | COMPOSITIONS AND METHODS FOR INCREASING GLUTATHIONE LEVELS | REYNOLDS, FRED H | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18370919 | COMPOSITIONS AND METHODS FOR INCREASING GLUTATHIONE LEVELS | REYNOLDS, FRED H | — |
| Art Unit | Apps |
|---|---|
| 1625 | 1 |
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18370931 | COMPOSITIONS AND METHODS FOR PREVENTING AND/OR TREATING TUBERCULOSIS AND MRSA | SEAMAN, D MARGARET M | 1625 | §103§112DP | Non-Final OA | — | Pending | Sep 21, 2023 |
| 18370919 | COMPOSITIONS AND METHODS FOR INCREASING GLUTATHIONE LEVELS | REYNOLDS, FRED H | 1658 | §101§103§112DP | Final Rejection | — | Pending | Sep 21, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial